Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
Emory University
Emory University
Hospital Universitario de Móstoles
Columbia University
Hospital Universitario La Fe
Istanbul Medipol University Hospital
Hospital Frydek-Mistek
Hospital Provincial de Castellon
Parc de Salut Mar
Washington University School of Medicine
Instituto Ecuatoriano de Enfermedades Digestivas
Maimónides Biomedical Research Institute of Córdoba
Asian Institute of Gastroenterology, India
Indiana University
University of Pennsylvania
Military University Hospital, Prague
Hospital Frydek-Mistek
Société Française d'Endoscopie Digestive
Technical University of Munich
McMaster University
Chinese University of Hong Kong